Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-13-001164
Filing Date
2013-06-11
Accepted
2013-06-11 19:07:20
Documents
1
Period of Report
2013-06-07

Document Format Files

Seq Description Document Type Size
1 form4-06112013_110611.html 4  
1 form4-06112013_110611.xml 4 4119
  Complete submission text file 0001415889-13-001164.txt   5448
Mailing Address 3911 SORRENTO VALLEY BLVD SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SAN DIEGO CA 92121 858-558-2871
ACADIA PHARMACEUTICALS INC (Issuer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address SMEDENS AGER 6 NORUP DK-7182 BREDSTEN G7 DK-7182
Business Address
Rasmussen Torsten (Reporting) CIK: 0001291881 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50768 | Film No.: 13907353